BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31851456)

  • 21. Mass screening of prostate cancer in Changchun City of China.
    Li X; Tsuji I; Kuwahara M; Zhang H; Wang H; Zhang L; Ji G; Zhao X
    Int Urol Nephrol; 2004; 36(4):541-8. PubMed ID: 15787333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases.
    Jia Y; Zhu LY; Xian YX; Sun XQ; Gao JG; Zhang XH; Hou SC; Zhang CC; Liu ZX
    World J Surg Oncol; 2017 Aug; 15(1):165. PubMed ID: 28851376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
    Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
    Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mass screening for prostate cancer in Tokushima City: the results of 2001].
    Kanayama HO; Kagawa S; Utsunomiya M; Kawashima S; Takehisa I; Sumitani H; Yokozeki H
    Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):596-603. PubMed ID: 15103922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended use of P504S positive primary circulating prostate cell detection to determine the need for initial prostate biopsy in a prostate cancer screening program in Chile.
    Murray NP; Reyes E; Fuentealba C; Jacob O; Orellana N
    Asian Pac J Cancer Prev; 2014; 15(21):9335-9. PubMed ID: 25422221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 Years.
    Goldberg H; Klaassen Z; Chandrasekar T; Wallis CJD; Toi A; Sayyid R; Bhindi B; Nesbitt M; Evans A; van der Kwast T; Sweet J; Perlis N; Hamilton RJ; Kulkarni GS; Finelli A; Zlotta A; Fleshner N
    J Urol; 2018 Nov; 200(5):1056-1061. PubMed ID: 29758220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age.
    Iwamoto H; Izumi K; Kadomoto S; Makino T; Naito R; Yaegashi H; Shigehara K; Kadono Y; Mizokami A
    Asian J Androl; 2021; 23(1):36-40. PubMed ID: 32769233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
    Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
    BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases.
    Gomez-Guerra LS; Martinez-Fierro ML; Alcantara-Aragon V; Ortiz-Lopez R; Martinez-Villarreal RT; Morales-Rodriguez IB; Garza-Guajardo R; Ponce-Camacho MA; Rojas-Martinez A
    BMC Cancer; 2009 Mar; 9():91. PubMed ID: 19317909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997.
    Roberts RO; Bergstralh EJ; Lieber MM; Jacobsen SJ
    Urology; 2000 Nov; 56(5):817-22. PubMed ID: 11068309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing.
    Eklund M; Nordström T; Aly M; Adolfsson J; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Presti JC; StLezin M; Clements M; Egevad L; Grönberg H
    Eur Urol Focus; 2018 Sep; 4(5):707-710. PubMed ID: 28753803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy.
    Spurgeon SE; Mongoue-Tchokote S; Collins L; Priest R; Hsieh YC; Peters LM; Beer TM; Mori M; Garzotto M
    Urology; 2007 May; 69(5):931-5. PubMed ID: 17482937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening for early detection of prostate cancer (first experience in Israel)].
    Neheman A; Shotland Y; Metz Y; Stein A
    Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
    J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
    el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD
    Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran.
    Safarinejad MR
    Ann Oncol; 2006 Jul; 17(7):1166-71. PubMed ID: 16684791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.